Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
KJ Martin, EA González - Clinical Journal of the American Society …, 2011 - journals.lww.com
Phosphate retention and, later, hyperphosphatemia are key contributors to chronic kidney
disease (CKD)–mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
disease (CKD)–mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
[引用][C] Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
M KJ - Clin J Am Soc Nephrol, 2011 - cir.nii.ac.jp
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD : what is
normal, when to start, and how to treat? | CiNii Research CiNii 国立情報学研究所 学術情報 …
normal, when to start, and how to treat? | CiNii Research CiNii 国立情報学研究所 学術情報 …
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
KJ Martin, EA González - Clinical Journal of the American Society of …, 2011 - europepmc.org
Phosphate retention and, later, hyperphosphatemia are key contributors to chronic kidney
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
KJ Martin, EA González - Clinical Journal of the American Society of …, 2011 - hero.epa.gov
Phosphate retention and, later, hyperphosphatemia are key contributors to chronic kidney
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
KJ Martin, EA González - Clinical journal of the American …, 2011 - pubmed.ncbi.nlm.nih.gov
Phosphate retention and, later, hyperphosphatemia are key contributors to chronic kidney
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
disease (CKD)-mineral and bone disorder (MBD). Phosphate homeostatic mechanisms …
[引用][C] Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
M KJ - Clin J Am Soc Nephrol, 2011 - cir.nii.ac.jp
Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD : what is
normal, when to start, and how to treat? | CiNii Research CiNii 国立情報学研究所 学術情報 …
normal, when to start, and how to treat? | CiNii Research CiNii 国立情報学研究所 学術情報 …